AK Medical Holdings Limited

HKEX:1789.HK

4.15 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 712.051480.94733.633584.417531.211313.808447.633556.407478.979488.922437.783231.676325.555275.007150.141210.183162.51793.175155.43115.34767.69467.69451.54151.54151.54151.54137.0737.0737.0737.07
Cost of Revenue 280.249201.684279.482256.416192.676122.952139.3178.198142.656150.25133.20470.864107.48384.19847.9258.09650.81427.22847.99635.4720.86720.86716.02716.02716.02716.02711.73311.73311.73311.733
Gross Profit 431.802279.256454.151328.002338.535190.856308.333378.209336.323338.672304.579160.813218.072190.809102.22152.087111.70365.948107.43479.87746.82846.82835.51435.51435.51435.51425.33625.33625.33625.336
Gross Profit Ratio 0.6060.5810.6190.5610.6370.6080.6890.680.7020.6930.6960.6940.670.6940.6810.7240.6870.7080.6910.6920.6920.6920.6890.6890.6890.6890.6830.6830.6830.683
Reseach & Development Expenses 68.89176.48975.0163.35954.39961.33251.73761.07443.945.39335.13420.13226.0319.56511.39917.03417.9298.74112.1248.2665.0985.0984.724.724.724.723.8853.8853.8853.885
General & Administrative Expenses 058.2775.17163.77754.53654.2851.03644.75638.2643.98347.5623.05138.49135.63418.53136.94618.27614.05619.22118.89412.57312.5738.0088.0088.0088.0084.8194.8194.8194.819
Selling & Marketing Expenses 0101.399117.40780.39499.713108.62678.72191.35162.7590.92784.40743.83472.68550.19230.71930.73719.6612.59922.13114.0982.3812.3811.9311.9311.9311.9310.8130.8130.8130.813
SG&A 200.812156.906217.797155.506154.249162.906129.757136.107101.01134.91131.96766.884111.17685.82649.25167.68337.93626.65541.35232.99214.95314.9539.9389.9389.9389.9385.6325.6325.6325.632
Other Expenses 0000000000-1.873-1.873-1.873-60.51-60.51-60.51-0.67-0.67-0.673.4353.4353.4352.6172.6172.6172.6171.3721.3721.3721.372
Operating Expenses 269.703233.395292.807218.865196.379217.291180.722205.01144.591179.712151.60985.143134.948104.5630.13985.45954.06534.72651.42341.32823.48523.48517.27517.27517.27517.27510.88910.88910.88910.889
Operating Income 162.09945.861161.344109.136134.843-29.483128.919185.418192.356165.86137.47880.51785.3685.86743.62568.19657.69231.34655.66937.70123.75723.75718.98818.98818.98818.98815.07415.07415.07415.074
Operating Income Ratio 0.2280.0950.220.1870.254-0.0940.2880.3330.4020.3390.3140.3480.2620.3120.2910.3240.3550.3360.3580.3270.3510.3510.3680.3680.3680.3680.4070.4070.4070.407
Total Other Income Expenses Net 14.01633.14317.333-7.21214.6116.432.693-5.6824.515-0.90718.971-0.1661.1872.0860-0.9820.47800.6690.9880000000000
Income Before Tax 176.11579.004178.677101.925149.454-23.053131.612179.736196.871164.953156.44980.35186.54787.95343.62567.21458.1731.34656.33838.68923.75723.75718.98818.98818.98818.98815.07415.07415.07415.074
Income Before Tax Ratio 0.2470.1640.2440.1740.281-0.0730.2940.3230.4110.3370.3570.3470.2660.320.2910.320.3580.3360.3620.3350.3510.3510.3680.3680.3680.3680.4070.4070.4070.407
Income Tax Expense 25.21725.49528.74213.57423.4214.18920.12928.63427.51626.89413.60313.00316.5617.39111.8888.125.00212.2345.4674.4254.4252.7612.7612.7612.7612.1442.1442.1442.144
Net Income 150.89853.509149.93588.351126.033-18.864111.483151.136162.871137.437129.55566.74873.54471.39236.23455.32650.0526.34444.10433.22219.33219.33216.22716.22716.22716.22712.9312.9312.9312.93
Net Income Ratio 0.2120.1110.2040.1510.237-0.060.2490.2720.340.2810.2960.2880.2260.260.2410.2630.3080.2830.2840.2880.2860.2860.3150.3150.3150.3150.3490.3490.3490.349
EPS 0.140.0480.140.080.11-0.020.10.130.150.130.120.0630.070.0690.0350.070.0670.0350.0560.0440.0190.0190.0160.0160.0160.0160.0130.0130.0130.013
EPS Diluted 0.140.0480.130.0790.11-0.0170.10.140.150.130.120.0630.070.0690.0350.0720.0670.0350.0590.0440.0190.0190.0160.0160.0160.0160.0130.0130.0130.013
EBITDA 162.09996.232211.461153.482175.723-8.547165.399203.001218.375181.141152.39788.55696.68493.56248.8174.07663.45834.40660.25541.43925.9525.9520.2620.2620.2620.2616.20516.20516.20516.205
EBITDA Ratio 0.2280.20.2880.2630.331-0.0270.3690.3650.4560.370.3480.3820.2970.340.3250.3520.390.3690.3880.3590.3830.3830.3930.3930.3930.3930.4370.4370.4370.437